Fig. 1From: Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve diseaseComparison of serum ESM-1 concentration in control, MMVD, MMVD substages, death, and alive group. A No significant difference in serum ESM-1 concentration between the control group and substages of MMVD, B ESM-1 concentration was significantly higher in the death group compared to the alive group in MMVD dogs. Abbreviations: ESM-1, endothelial cell-specific molecule-1; MMVD, myxomatous mitral valve diseaseBack to article page